A previous study has demonstrated that LINC01537 was significantly associated with lung cancer survival, inhibiting tumor proliferation and metastasis, as well as enhanced cellular sensitivity to nilotinib through stabilized PDE2A protein [36]. Here, PDE2A is linked to lung cancer.